News
SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has rec ...
Feline Fam on MSN7h
Miraculous Cat Void Saves Owner’s Life Multiple Times and Earns National Hero AwardA miraculous grey Russian Blue cat named Void has achieved something extraordinary that defies medical explanation – ...
Wolff-Parkinson-White Syndrome is a type of arrhythmia that is commonly diagnosed in young people and infants Here’s all you ...
Field Medical has generated another $35 million in venture capital funding for its cardiac pulsed field ablation system to support the launch of a pivotal trial. | The series B financing comes quickly ...
Stereotaxis (NYSE:STXS) announced the publication of initial clinical results using its MAGiC robotic magnetic navigation ...
On Monday, plaintiffs’ lawyers filed their opening brief asking the U.S. Court of Appeals for the Fourth Circuit to reinstate ...
The medtech startup founded by physician and Farapulse inventor Steven Mickelsen is preparing to begin a pivotal study of ...
BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia ...
In a lawsuit filed against Middlesex Health System, Inc., Middlesex Hospital, and Middlesex Health Services, Inc. at Superior ...
Despite the absence of pain signals, post-operative opioids control tachycardia and hypertension, highlighting the unique ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results